CELL-FREE DNA PREDICTS HIV REBOUND TIMING FOLLOWING ANTIRETROVIRAL THERAPY CESSATION
The development of HIV cure strategies depends on our capacity to predict HIV rebound when antiretroviral therapy (ART) is stopped. Here, we applied a systems profiling approach to the analytical treatment interruption (ATI) framework, to identify circulating plasma factors that enable non-invasive prediction of viral rebound kinetics post-ART cessation. Plasma samples were retrospectively collected from…